Outcomes of Human Papilloma Virus Vaccination in a Private Women Health Clinic in Lebanon

Table 1

Distribution of the human papilloma virus vaccination for women and their adolescent girls attending the Women’s Health Center (WHC) of the American University of Beirut-Medical Center (AUBMC) 2007–2017.

Year intervals	Doses	Age ≤25	Age >25	Total	value
2007–2012	2 doses	26% (15/47)	74% (42/57)	11.6% (57/493)
	3 doses	42% (184/436)	58% (252/436)	88.4% (436/493)
Total		40% (199/493)	60% (294/493)	493
2013–2017	2 doses	48% (44/92)	52% (48/92)	25% (92/367)	0.091
	3 doses	58% (160/275)	42% (115/275)	75% (275/367)
Total		56% (204/367)	44% (163/367)	367
2007–2017	2 doses	40% (59/149)	60% (90/149)	17% (149/860)	0.058
	3 doses	48.4% (344/711)	51.6% (367/711)	83% (711/860)
	Total	47% (403/860)	53% (457/860)	860